Editor´s Pick

Editor´s Pick

First-of-Its-Kind Study Uses Smartphone to Track Cystic Fibrosis in Real Life

BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced the initiation of the HERO-2: Home Reported Outcomes Study, a first-of-its-kind, at-home observational study that aims...

Admin - June 2, 2021

Editor´s Pick

Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States

KENILWORTH, N.J. & BRIDGEWATER, N.J.--(BUSINESS WIRE)--VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed as...

Admin - June 1, 2021

Editor´s Pick

Moderna Announces TeenCOVE Study of its COVID-19 Vaccine in Adolescents Meets Primary Endpoint and Plans to Submit Data to Regulators in Early June

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Phase 2/3 study of...

Admin - May 25, 2021

Editor´s Pick

ImmunityBio Expands Trials of T-Cell-Based COVID-19 Vaccine Candidate as a ‘Universal Boost’ in Vaccinated Subjects and Receives Approval to Test Intranasal Spray in South...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced two South African studies to examine the potential for using its...

Admin - May 25, 2021

Editor´s Pick

Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

CAMBRIDGE, Mass. & FARGO, N.D.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider...

Admin - May 24, 2021

Editor´s Pick

Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Ministry of Health, Labour...

Admin - May 21, 2021

1 234...54 Page 3 of 54

Recent Articles

Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients

Dicerna Announces Dosing Completion in Nedosiran PHYOX™4 Clinical Trial for Treatment of Primary Hyperoxaluria Type 3

Can-Fite Receives Notice of Patent Allowance in China for NASH Treatment

Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel...

U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine

ReViral Announces Positive Recommendation by the Data Safety Monitoring Committee to Continue the Phase 2 Clinical Study of Sisunatovir for Treatment of Respiratory Syncytial...

Seventy-Four Percent of Pharmaceutical Marketing Executives Say Changes in Third-Party Cookie Management Will Be Impactful or Very Impactful on Their Media Plans

Walmart Provides Digital COVID-19 Vaccine Record

Real Chemistry Appoints Mary Stutts as Global Chief Inclusion and Health Equity Officer

Arnaud Lacoste Is Named Chief Scientific Officer of Aurion Biotech

Deepcell Expands Advisory Board with Stanford’s Dr. Christina Curtis

PharmaJet Announces Addition of Paul LaBarre as VP Global Business Development

Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates

Ashvattha Therapeutics Announces Positive Interim Data from Ongoing Phase 2 PRANA Clinical Study of OP-101 in Severe COVID-19 Patients

Exscientia Acquires Personalised Medicine AI Pioneer Allcyte